|
Volumn 34, Issue 7, 2002, Pages 2823-
|
Influence of the type of renal replacement therapy on peritonitis rate after simultaneous pancreas kidney transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
CYCLOSPORIN;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ANTIBIOTIC PROPHYLAXIS;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
EUROPE;
FOLLOW UP;
GRAFT REJECTION;
HEMODIALYSIS;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
ISRAEL;
KIDNEY TRANSPLANTATION;
LEUKOCYTOSIS;
MAJOR CLINICAL STUDY;
MORTALITY;
MULTICENTER STUDY;
PANCREAS SECRETION;
PANCREAS TRANSPLANTATION;
PERCUTANEOUS DRAINAGE;
PERITONEAL DIALYSIS;
PERITONITIS;
POSTOPERATIVE HEMORRHAGE;
POSTOPERATIVE INFECTION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
SURGICAL DRAINAGE;
ARTICLE;
COMPARATIVE STUDY;
METHODOLOGY;
PHYSIOLOGY;
POSTOPERATIVE COMPLICATION;
RENAL REPLACEMENT THERAPY;
ANTIBIOTIC PROPHYLAXIS;
HUMANS;
KIDNEY TRANSPLANTATION;
PANCREAS TRANSPLANTATION;
PERITONEAL DIALYSIS;
PERITONITIS;
POSTOPERATIVE COMPLICATIONS;
RENAL DIALYSIS;
RISK FACTORS;
|
EID: 18644373686
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)03529-7 Document Type: Conference Paper |
Times cited : (9)
|
References (2)
|